International Parkinson and Movement Disorder Society®

Congratulations to Susan Fox on receiving the 2026 PAS Leadership Award! #PASCongress

More than 230 abstracts are being presented at the #PASCongress. View the published open-access abstracts: https://loom.ly/0F_rvso and Late-Breaking Abstracts: https://loom.ly/S4R4XKU

MDS wishes to acknowledge the following supporters of the 2026 #PASCongress.

MDS wishes to acknowledge the following Bronze Level supporters of the 2026 #PASCongress: Acadia and Amneal Pharmceuticals (Marquee Sponsor).

MDS wishes to acknowledge the following Silver Level supporter of the 2026 #PASCongress: Praxis Precision Medicines.

MDS wishes to acknowledge the following Gold Level supporters of the 2026 #PASCongress: AskBio, Medtronic, Neurocrine Biosciences Inc., and Teva Pharmaceuticals.

MDS wishes to acknowledge the following Platinum Level supporters of the 2026 #PASCongress: Abbvie, Biogen, and Supernus Pharmaceuticals.

Top opportunity for young neurologists in Africa - apply soon! https://loom.ly/4eQD3E4

2026 International Congress abstract submissions are now open. Submit now » https://loom.ly/22Jj9eo

Share a case for expert discussion! https://loom.ly/aixrunM

The current HD-ISS doesn't incorporate wet biomarkers. Dr. Mena Farag discusses the promising results of proenkephalin and other biomarkers to help monitor the earliest stages of HD before the onset of motor symptoms. https://loom.ly/j3VrGFs

Apply to join the newly established global MDS Task Force on Chorea Classification, which will develop an axis-based system for classifying chorea loom.ly/VtFtGos

Experts debate breakthroughs in disease-modifying therapies for monogenic PD, the relevant role of AI in diagnosis, and whether protein-targeted approaches help or hinder disease progression. #PASCongress pascongress.org

Unlike the social components of stigma, shame is more about self identification alongside disease. Dr. Vanessa Fleury shares how shame may present itself in PD and how clinicians can work with patients to address it. https://loom.ly/ppaGPYA

Join the 5th Movement Disorders Clinical Practice Conference on May 10 in Lübeck, Germany. A practical look at genetics and lifestyle approaches in movement disorders care. Free registration available. https://loom.ly/bqTr8Zw

In 2016, a proposal for naming genetically determined movement disorders addressed difficulties with conventional naming systems. After nearly 10 years, an evaluation of its strengths and weaknesss: https://loom.ly/KRcFvqc

MDS’s Pediatric Movement Disorders Special Interest Group contributed to this investigation of NKX2-1-related disorders, which found that chorea affects over 90% of diagnosed patients. Foremost treatment was levodopa or methylphenidate. https://loom.ly/UCrX3fY

As an MDS member, you don’t just stay informed — you shape the future.

Renew for 2026 to continue shaping science and care.
https://loom.ly/EJBg2vU

Apply now: MDS Task Force on Chorea Classification https://loom.ly/VtFtGos

Gain an up-to-date look at current ataxia treatments, emerging disease-modifying strategies, and future innovations including biomarkers and gene therapy. #PASCongress pascongress.org

“Essentially, this course changed my whole approach to the patient.”
Join a faculty of foremost leaders in the field to gain a comprehensive understanding of these complex diseases. https://loom.ly/cuegghw

There is limited guidance on helping women with PD before, during, and after pregnancy. Dr. Alexander Lehn shares how a recent review sought to address these gaps so that clinicians can more confidently converse with their patients about family planning. https://loom.ly/tFcbA2w

Collaborate with leading experts to analyze real cases — or even share your own. https://loom.ly/aixrunM

Browse the cutting-edge #PASCongress scientific sessions and events, including Novel Clinical Trials, Ataxia Therapies, Controversies in Movement Disorders, and more. https://loom.ly/lLFU9S8

Join international experts to decode the biological and environmental drivers of PD and explore their clinical implications. https://loom.ly/5t7ZSPo

Come together with hundreds of renowned physicians, researchers and other professionals from across Pan America to build partnerships and advance the science of Movement Disorders. mdscongress.org

Deadline soon: Explore genetics, collaboration, and opportunities across Africa. https://loom.ly/0bQy-Lo

Gastrointestinal dysfunction has been increasingly regarded as an integral aspect of PD and have been associated with various symptoms. This MDS Podcast discusses the use of probiotics in PD, specifically regarding constipation. https://loom.ly/s_ehJKI

Submit an abstract to be presented at the International Congress of Parkinson's Disease and Movement Disorders® in Seoul, Korea. https://loom.ly/22Jj9eo

Wellness Study Group The Wellness Task Force aims to create a framework for systematically addressing wellness in PD defined as the active pursuit of activities, choices and lifestyles that lead to a state of holistic health combining motor and non-motor benefits. 

New MDS Study Group:
Join the Wellness Study Group, focused on advancing research and best practices in wellness for movement disorders. Learn more & get involved:
https://loom.ly/tLf9ZWo